Stocktwits on MSN
SLS Stock Rises Overnight: Traders Rally Behind Jim Cramer's 'Two Thumbs Up' Call Ahead Of Key AML Readout
CNBC's Jim Cramer called Sellas Life Sciences "a great spec" and gave the biotech stock "two thumbs up" during Mad Money's Lightning Round. ・Investor focus remains on Sellas' Phase 3 Regal trial ...
The FDIC, along with the OCC and NCUA, and the Financial Crimes Enforcement Network (FinCEN) have proposed changes to the ...
New York City-based Community Federal Savings Bank, a partner to Wise and Crypto.com, faces an enforcement action over what ...
As global regulations continue to tighten, FinTech Magazine profiles some of the leading AML software providers delivering ...
Acute myeloid leukemia (AML) is a type of blood and bone marrow cancer. AML can affect people of any age, but it is most common in adults. AML occurs when bone marrow produces abnormal blood cells, ...
The Court of Appeal has rejected automatic AML misconduct findings, but firms face intensifying regulatory scrutiny and ...
A survey of 334 compliance professionals across the UK’s regulated sectors by compliance eLearning and software provider, ...
IRVINE, Calif., May 31, 2011 (GLOBE NEWSWIRE) -- Microsemi Corporation (Nasdaq:MSCC), a leading provider of semiconductor technology aimed at building a smart, secure, connected world, today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results